Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Oncotelic Therapeutics, Inc. (MATN)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | | | | | -364.0% | -321.1% | | |
| ROIC (including intangibles) | -70.0% | -50.5% | -24.3% | -28.9% | 901.0% | -150.5% | 2397.2% | -2665.7% |
| ROE | -109.5% | -57.9% | -25.5% | -28.9% | 2901.9% | -110.1% | -54.0% | -43.6% |
| ROA | -34.5% | -30.5% | -18.2% | -25.9% | -1181.1% | -97.5% | -49.8% | -41.6% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | 4.1 | | | | | | |
| Days payables outstanding | | | | | | | | |
| Cash conversion cycle | | | | | | | | |
|